Open AccessFetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
Author(s) -
Reverté Laia,
Yeregui Elena,
Olona Montserrat,
GutiérrezValencia Alicia,
Buzón Maria José,
Martí Anna,
GómezBertomeu Frederic,
Auguet Teresa,
LópezCortés Luis F.,
Burgos Joaquin,
BenaventBofill Clara,
Boqué Carme,
GarcíaPardo Graciano,
RuizMateos Ezequiel,
Mestre Maria Teresa,
Vidal Francesc,
Viladés Consuelo,
Peraire Joaquim,
Rull Anna
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.704
Subject(s) - medicine , cohort , disease , comorbidity , biomarker , metabolome , immune dysregulation , diabetes mellitus , severity of illness , cohort study , lipidome , intensive care medicine , biology , endocrinology , lipid metabolism , biochemistry , metabolite